|
|
 Previous Article | Table of Contents | Next Article 
Thrombosis and Secondary Hemochromatosis Play Major Roles in the Pathogenesis of Jaundiced and Spherocytic Mice, Murine Models for Hereditary Spherocytosis
Tamma M. Kaysser,
Nancy J. Wandersee,
Rod T. Bronson, and
Jane E. Barker
From The Jackson Laboratory, Bar Harbor, ME; and Tufts University School of Veterinary Medicine, Boston, MA.
Jaundiced mice, ja/ja, suffer from a severe hemolytic anemia caused by a complete deficiency of erythroid  -spectrin. We used these mice as a model to investigate the pathophysiological consequences of the deficiency, including the effects in the nonerythroid tissues where this protein is expressed. Because the ja/ja mice rarely survive beyond the fourth postnatal day, methods were assessed for extending lifespan into adulthood. Neonatal transfusion increased lifespan to a mean of 3.7 months, allowing a more complete characterization of the pathophysiology. Blood parameters and histopathology of the jaundiced mouse were compared with that from spherocytic mice, which have a hemolytic anemia caused by deficiency of erythroid  -spectrin, yet can survive the postnatal period transfusion free. The adult jaundiced and spherocytic mice present with greatly decreased hematocrit and red blood cell counts, reticulocytosis, and bilirubinemia, leading secondarily to hepatosplenomegaly and cardiomegaly. Jaundiced and spherocytic mice were analyzed histopathologically between 1.0 and 9.5 months of age. Interestingly, the complete absence of erythroid -spectrin in jaundiced mice leads to no detectable structural defects in brain, cardiac, or skeletal muscles. However, fibrotic lesions and lymphocytic infiltration were observed in cardiac tissue from 4 of 13 jaundiced mice and 15 of 15 spherocytic mice, and thrombi were detected at either the atrioventricular valves or within the atria of 2 of 13 jaundiced mice and 15 of 15 spherocytic mice. In addition, all affected mice had a progressive renal hemosiderosis concurrent with hydronephrosis and glomerulonephritis. The severity of the renal disease and its presence in all moribund mice suggests kidney failure rather than the fibrotic heart lesions as the major cause of death in these mice.
Blood, Vol. 90 No. 11 (December 1), 1997:
pp. 4610-4619
© 1997 by The American Society of Hematology.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
S. E. Crary and G. R. Buchanan
Vascular complications after splenectomy for hematologic disorders
Blood,
October 1, 2009;
114(14):
2861 - 2868.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. C. Frei, Y. Guo, D. W. Jones, K. A. Pritchard Jr, K. A. Fagan, N. Hogg, and N. J. Wandersee
Vascular dysfunction in a murine model of severe hemolysis
Blood,
July 15, 2008;
112(2):
398 - 405.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Sanefuji, S. Ohga, R. Kira, and T. Yoshiura
Moyamoya Syndrome in a Splenectomized Patient With {beta}-Thalassemia Intermedia
J Child Neurol,
January 1, 2006;
21(1):
75 - 77.
[Abstract]
[PDF]
|
|
|
|
|
|
|
K. Yoshizawa, G. E. Kissling, J. A. Johnson, N. P. Clayton, N. D. Flagler, and A. Nyska
Chemical-Induced Atrial Thrombosis in NTP Rodent Studies
Toxicol Pathol,
August 1, 2005;
33(5):
517 - 532.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. J. Wandersee, S. C. Olson, S. L. Holzhauer, R. G. Hoffmann, J. E. Barker, and C. A. Hillery
Increased erythrocyte adhesion in mice and humans with hereditary spherocytosis and hereditary elliptocytosis
Blood,
January 15, 2004;
103(2):
710 - 716.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. J. Wandersee, C. S. Birkenmeier, D. M. Bodine, N. Mohandas, and J. E. Barker
Mutations in the murine erythroid alpha -spectrin gene alter spectrin mRNA and protein levels and spectrin incorporation into the red blood cell membrane skeleton
Blood,
January 1, 2003;
101(1):
325 - 330.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Eldor and E. A. Rachmilewitz
The hypercoagulable state in thalassemia
Blood,
January 1, 2002;
99(1):
36 - 43.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. J. Wandersee, J. C. Lee, S. A. Deveau, and J. E. Barker
Reduced incidence of thrombosis in mice with hereditary spherocytosis following neonatal treatment with normal hematopoietic cells
Blood,
June 15, 2001;
97(12):
3972 - 3975.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. J. Wandersee, A. N. Roesch, N. R. Hamblen, J. de Moes, M. A. van der Valk, R. T. Bronson, J. A. Gimm, N. Mohandas, P. Demant, and J. E. Barker
Defective spectrin integrity and neonatal thrombosis in the first mouse model for severe hereditary elliptocytosis
Blood,
January 15, 2001;
97(2):
543 - 550.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Williams, W. Resneck, T Kaysser, J. Ursitti, C. Birkenmeier, J. Barker, and R. Bloch
Na,K-ATPase in skeletal muscle: two populations of beta-spectrin control localization in the sarcolemma but not partitioning between the sarcolemma and the transverse tubules
J. Cell Sci.,
January 2, 2001;
114(4):
751 - 762.
[Abstract]
[PDF]
|
|
|
|
|
|
|
B I Ghanayem, S M Ward, B Chanas, and A Nyska
Comparison of the acute hematotoxicity of 2-butoxyethanol in male and female F344 rats
Human and Experimental Toxicology,
March 1, 2000;
19(3):
185 - 192.
[Abstract]
[PDF]
|
|
|
|
|
|
|
F. Delhommeau, T. Cynober, P. O. Schischmanoff, P. Rohrlich, J. Delaunay, N. Mohandas, and G. Tchernia
Natural history of hereditary spherocytosis during the first year of life
Blood,
January 15, 2000;
95(2):
393 - 397.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Liao, B. Paw, L. Peters, A Zapata, S. Pratt, C. Do, G Lieschke, and L. Zon
Hereditary spherocytosis in zebrafish riesling illustrates evolution of erythroid beta-spectrin structure, and function in red cell morphogenesis and membrane stability
Development,
January 12, 2000;
127(23):
5123 - 5132.
[Abstract]
[PDF]
|
|
|
|
|
|
|
A. Nyska, R. R. Maronpot, P. H. Long, J. H. Roycroft, J. R. Hailey, G. S. Travlos, and B. I. Ghanayem
Disseminated Thrombosis and Bone Infarction in Female Rats Following Inhalation Exposure to 2-Butoxyethanol
Toxicol Pathol,
May 1, 1999;
27(3):
287 - 294.
[Abstract]
[PDF]
|
|
|
|
|
|
|
F. Lellouche, I. Dorval, J. M. Corvisier, P. Jezequel, L. Campion;, S.A.M. Taylor, D. Lillicrap, and T.P. Baglin
C282Y Hemochromatosis Mutation Does Not Contribute to Hypercoagulability in a Factor V Leiden Population Referred for Venous Thrombosis
Blood,
March 15, 1999;
93(6):
2135 - 2136.
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. J. Wandersee, J. C. Lee, T. M. Kaysser, R. T. Bronson, and J. E. Barker
Hematopoietic Cells From alpha -Spectrin-Deficient Mice Are Sufficient to Induce Thrombotic Events in Hematopoietically Ablated Recipients
Blood,
December 15, 1998;
92(12):
4856 - 4863.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Hassoun, Y. Wang, J. Vassiliadis, M. Lutchman, J. Palek, L. Aish, I. S. Aish, S.-C. Liu, and A. H. Chishti
Targeted Inactivation of Murine Band 3 (AE1) Gene Produces a Hypercoagulable State Causing Widespread Thrombosis In Vivo
Blood,
September 1, 1998;
92(5):
1785 - 1792.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y.-G. Xie, D. P. Lillicrap, and S. A.M. Taylor
An Association Between the Common Hereditary Hemochromatosis Mutation and the Factor V Leiden Allele in a Population With Thrombosis
Blood,
August 15, 1998;
92(4):
1461 - 1462.
[Full Text]
[PDF]
|
|
|
|
|
